Assesment of Two Different Modalities of Maxillary Canine Retraction Assisted With Injectable Platelet Rich Fibrin

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-01

Study Completion Date

2023-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present prospective clinical study will be undertaken for assessment of two different modalities of maxillary canine retraction assisted with injectable platelet rich fibrin.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy of Injectable Platelet Rich Fibrin (i-PRF) in Enhancing Bone Quality

NCT03399760

Malocclusion, Angle Class II, Division 1

COMPLETED NA

The Effect of Multiple Injections of (PRF) on The Rate of Canine Retraction

NCT05766618

Platelet-Rich Fibrin Acceleration Orthodontics

UNKNOWN PHASE3

Efficacy of Biological Technique in Upper Canine Retraction and Levels of Discomfort

NCT03399422

Malocclusion, Angle Class II, Division 1

COMPLETED NA

The Effect of Platelet-rich Fibrin and Vitamin Dꝫ Injections on Canine Retraction

NCT06071455

Acceleration of Tooth Movement

UNKNOWN NA

Effect of Injectable Platelet-rich Fibrin on the En Masse Retraction of Maxillary Anterior Teeth

NCT05608356

Platelet-rich Fibrin

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Effect of Platelet Rich Fibrin Tooth Movement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I

will include 9 patients

Group Type ACTIVE_COMPARATOR

Injectable platelet rich fibrin .

Intervention Type BIOLOGICAL

i-PRF with maxillary canine retraction that will be performed two times on intervention sides according to a standardized protocol.

Group II

will include 9 patients.

Group Type ACTIVE_COMPARATOR

Injectable platelet rich fibrin .

Intervention Type BIOLOGICAL

i-PRF that will be performed four times on intervention sides according to a standardized protocol.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Injectable platelet rich fibrin .

i-PRF with maxillary canine retraction that will be performed two times on intervention sides according to a standardized protocol.

Intervention Type BIOLOGICAL

Injectable platelet rich fibrin .

i-PRF that will be performed four times on intervention sides according to a standardized protocol.

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* An age range from 15-22 years.
* Severe crowding or protrusion requiring 1st premolars extractions followed by symmetrical canine retraction.
* All permanent teeth present, 3rd molars are excluded.
* Good oral and general health.
* No systemic disease/medication that could interfere with OTM. No previous orthodontic treatment.

Exclusion Criteria

* Patient diagnosed to have an indication for non-extraction approach.
* Poor oral hygiene or periodontally compromised patient.
* Patient with craniofacial anomalies or previous history of trauma, bruxism or parafunctions.

Minimum Eligible Age

15 Years

Maximum Eligible Age

22 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes